Skip to main content
. 2010 Aug;161(2):290–297. doi: 10.1111/j.1365-2249.2010.04167.x

Fig. 1.

Fig. 1

Absolute Vγ9Vδ2 T cell numbers in patients treated with Zoledronate (Zol) + interleukin (IL)-2 prior to treatment (T0), and 3 (T3), 9 (T9) and 12 (T12) months after treatment. Yellow symbols, patients who died before T3; red symbols, patients who died before T9; blue symbols, patients who died before T12; green symbols, patients surviving past T12.